Company Valuation: Bright Minds Biosciences Inc.

Data adjusted to current consolidation scope
Fiscal Period: September 2021 2023 2024 2025 2026 2027 2028
Capitalization 1 107 8.11 6.562 598.2 1,015 - -
Change - - -19.09% 9,016.5% 69.7% - -
Enterprise Value (EV) 107 8.11 6.562 598.2 1,015 1,015 1,015
Change - - -19.09% 9,016.5% 69.7% 0% 0%
P/E ratio - -1.09x - -47.4x -13.5x -8x -7.96x
PBR - - - - - - -
PEG - - - - -0x -0.1x -14.73x
Capitalization / Revenue - - - - - - -
EV / Revenue - - - - - - -
EV / EBITDA - - - -0x -9.82x -4.91x -3.51x
EV / EBIT - - - -0x -12x -5.54x -4.35x
EV / FCF - - - -0x -10.5x -5.33x -3.96x
FCF Yield - - - -1.45% -9.52% -18.8% -25.3%
Dividend per Share 2 - - - - - - -
Rate of return - - - - - - -
EPS 2 - -1.98 - -1.78 -7.746 -13.04 -13.11
Distribution rate - - - - - - -
Net sales 1 - - - - - - -
EBITDA 1 - - - -13.67 -103.4 -206.8 -289.6
EBIT 1 - - - -13.75 -84.47 -183.3 -233.3
Net income 1 - -7.372 - -12.23 -82.77 -180.6 -214.8
Net Debt - - - - - - -
Reference price 2 45.20 2.15 1.47 84.39 104.31 104.31 104.31
Nbr of stocks (in thousands) 2,367 3,772 4,464 7,089 9,732 - -
Announcement Date 29/12/21 29/12/23 31/12/24 24/12/25 - - -
1CAD in Million2CAD
Estimates

P/E ratio, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
-13.47x - - - 744M
36.2x5.26x17.62x0.95% 46.82B
108.48x6.96x69.61x-.--% 39.16B
58.42x11.94x33.41x0.33% 32.9B
26.51x2.79x11.94x-.--% 31.8B
-17.45x4983.42x-16.28x-.--% 18.85B
36.62x5.92x26.9x-.--% 15.27B
Average 33.62x 836.05x 23.87x 0.21% 26.51B
Weighted average by Cap. 48.12x 514.15x 27.78x 0.3%
See all sector valuations

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. DRUG Stock
  4. Valuation Bright Minds Biosciences Inc.